Clinical trial
Study of Celecoxib Bioavailability in Healthy Subjects
NCT00296127 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry · Completed
Key facts
| NCT number | NCT00296127 |
|---|---|
| Title | Study of Celecoxib Bioavailability in Healthy Subjects |
| Official title | A Relative Bioavailability Study Of Celecoxib Administered As Capsule Contents Sprinkled On Applesauce In Healthy Adult Volunteers |
| Lead sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy Volunteers |
| Intervention type | Drug |
| Interventions | Celecoxib |
| Enrollment | 24 |
| Start date | Feb 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | Feb 24, 2006 |
| Last update posted | Mar 3, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: